Skip to main content
. 2018 Jun 5;2018(6):CD012713. doi: 10.1002/14651858.CD012713.pub2

Comparison 4. Subsidiary descriptive analysis: early versus late supportive care with ribavirin.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Mortality stratified by study type 5   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.1 Serious risk of bias 1 63 Risk Ratio (M‐H, Random, 95% CI) 0.39 [0.16, 0.95]
1.2 Critical risk of bias 4 431 Risk Ratio (M‐H, Random, 95% CI) 0.57 [0.38, 0.85]